Preformed Line Products Co: Form 10-K for the period ended Dec 31, 2019
Filed with the SEC on Mar 6, 2020 and accepted by EDGAR at Mar 6, 2020, 17:25 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-10-01 to 2019-12-31 | $113.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 12 months2019-01-01 to 2019-12-31 | $444.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2019-01-01 to 2019-12-31 | $304.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2019-10-01 to 2019-12-31 | $36.2m | us-gaap:GrossProfit |
| Gross profit | 12 months2019-01-01 to 2019-12-31 | $140.6m | us-gaap:GrossProfit |
| Research and development | 12 months2019-01-01 to 2019-12-31 | $3.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2019-01-01 to 2019-12-31 | $32.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2019-01-01 to 2019-12-31 | $2.2m | us-gaap:InterestExpense |
| Income tax | 12 months2019-01-01 to 2019-12-31 | $8.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-10-01 to 2019-12-31 | $5.6m | us-gaap:NetIncomeLoss |
| Net income | 12 months2019-01-01 to 2019-12-31 | $23.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-10-01 to 2019-12-31 | $1.09 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2019-01-01 to 2019-12-31 | $4.58 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-10-01 to 2019-12-31 | $1.12 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2019-01-01 to 2019-12-31 | $4.63 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2019-01-01 to 2019-12-31 | 5,087,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2019-01-01 to 2019-12-31 | $27.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2019-01-01 to 2019-12-31 | $29.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2019-01-01 to 2019-12-31 | $4.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2019-01-01 to 2019-12-31 | $2.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-12-31 | $38.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-12-31 | $232.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-12-31 | $433.6m | us-gaap:Assets |
| Current liabilities | At period end2019-12-31 | $81.1m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2019-12-31 | $53.7m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2019-12-31 | $3.4m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2019-12-31 | $12.1m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2019-12-31 | $268.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-20-009196. Last ingested by Listed: Nov 6, 2026, 07:10 ET. Listed shows no prices and gives no investment advice.